Bayer’s stock is jumping on secondary stroke drug’s trial success

Bayer’s stock is jumping on secondary stroke drug’s trial success



Bayer’s stock is jumping on secondary stroke drug’s trial success
Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals.


www.marketwatch.com
#Bayers #stock #jumping #secondary #stroke #drugs #trial #success

Share: X · Facebook · LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *